BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 23, 2020
View Archived Issues
Liver-derived protein helps lung, kidney repair
Read More
Acepodia studies ACE-1702 in phase I trial in advanced or metastatic HER2-expressing solid tumors
Read More
Microbiome-produced metabolites improve gut health
Read More
Targovax presents 12-month efficacy and immunological data for ONCOS-102 in mesothelioma
Read More
VP-01 demonstrates significant benefit in preclinical model of severe pulmonary hypertension
Read More
Positive safety data reported for AR-501 in healthy subjects
Read More
Shenzhen Targetrx Biotechnology patents Ret inhibitors
Read More
New phase I/IIa study investigates rigosertib plus nivolumab for lung adenocarcinoma
Read More
Shanghai Institute of Materia Medica presents TNF-alpha antagonists
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group discloses HBV antivirals
Read More
Betta Pharmaceuticals synthesizes new TRK inhibitors
Read More
Promising interim safety and immunogenicity phase II data presented for HB-101 vaccine
Read More
Interim trial data show antitumor activity with loncastuximab plus ibrutinib in DLBCL/MCL
Read More
HZDR divulges new TMEM97 ligands for PET imaging
Read More
Crescendo Biologics targets dysfunctional tumoral T cells with dual checkpoint inhibitor CB-213
Read More
First patient dosed in phase Ib study of nirogacestat plus belantamab mafodotin in multiple myeloma
Read More
Merck & Co. presents data from two phase III studies of V-114
Read More
LB-54640, the first oral MC4 receptor agonist for the treatment of rare genetic obesity
Read More
First-in-human study of in vivo imaging with Cu-64 SPION
Read More
miRagen reports preclinical observations with next-generation miR-29 mimic MRG-229 for IPF
Read More
FDA grants accelerated approval to Xpovio for relapsed or refractory DLBCL
Read More
Researchers find FOXD2 to be involved in syndromic CAKUT
Read More
AACR II: Innate immunity has good CAR-Ma for antitumor approaches
Read More
